big-gastrin and Glioblastoma

big-gastrin has been researched along with Glioblastoma* in 1 studies

Other Studies

1 other study(ies) available for big-gastrin and Glioblastoma

Article	Year
Association between post-operative hPG ESMO open, 2023, Volume: 8, Issue:5 Patients with glioblastomas have a dismal prognosis, and there is no circulating predictive or prognostic biomarker. Circulating progastrin, hPG. A multicentric retrospective study in glioblastoma patients treated with standard radio-chemotherapy was conducted. The hPG. Sixty-nine patients were assessable. Plasma samples were collected after tumor biopsy (B), partial resection (PR), and complete resection (CR) for 22, 25, and 22 patients, respectively. At a median concentration of 5.37 pM (interquartile range 0.00-13.90 pM), hPG. Circulating hPG Topics: Biomarkers; Glioblastoma; Humans; Prognosis; Retrospective Studies	2023

Article

Year

ESMO open, 2023, Volume: 8, Issue:5

Patients with glioblastomas have a dismal prognosis, and there is no circulating predictive or prognostic biomarker. Circulating progastrin, hPG. A multicentric retrospective study in glioblastoma patients treated with standard radio-chemotherapy was conducted. The hPG. Sixty-nine patients were assessable. Plasma samples were collected after tumor biopsy (B), partial resection (PR), and complete resection (CR) for 22, 25, and 22 patients, respectively. At a median concentration of 5.37 pM (interquartile range 0.00-13.90 pM), hPG. Circulating hPG

Topics: Biomarkers; Glioblastoma; Humans; Prognosis; Retrospective Studies

2023